Core Viewpoint - The article discusses China's responses to various international trade and diplomatic issues, particularly regarding soybean imports from the U.S., AI chip exports, and the fentanyl crisis, emphasizing China's consistent stance and openness to cooperation [2][3][4]. Group 1: Soybean Imports - China has resumed purchasing soybeans from the U.S. for the first time this harvest season after a period of zero imports in September [2]. Group 2: AI Chip Exports - The Chinese government has reiterated its position on the export of AI chips from the U.S. to China, suggesting that inquiries should be directed to relevant authorities [3]. Group 3: Fentanyl Crisis - China expresses sympathy for the fentanyl crisis affecting the U.S. and highlights its strict drug control policies, indicating a willingness to continue cooperation with the U.S. on this issue [4].

中方对美国人民遭受的芬太尼危机表示同情，曾为此提供帮助并取得积极效果，对继续同美方开展合作 持开放态度。美方应采取实际行动，为双方合作创造必要条件。(完) 来源：中国新闻网 中方：对美国人民遭受的芬太尼危机表示同情，美方应为合作创造必要条件 中新网北京10月29日电 (记者 谢雁冰)中国外交部发言人郭嘉昆29日主持例行记者会。有记者就中美元 首会晤可能谈及所谓"芬太尼关税"问题提问。 郭嘉昆：中方在这个问题上的立场是一贯的、明确的。中国是禁毒最坚决、政策最彻底、记录最良好的 国家，也是世界上列管物质最多、管制最严格的国家之一。 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 编辑：王永乐 广告等商务合作，请点击这里 ...

对此，中国外交部发言人郭嘉昆表示，中方在这个问题上的立场是一贯的、明确的。中国是禁毒最坚 决、政策最彻底、记录最良好的国家，也是世界上列管物质最多、管制最严格的国家之一。 他表示，中方对美国人民遭受的芬太尼危机表示同情，曾为此提供帮助并取得积极效果，对继续同美方 开展合作持开放态度。美方应采取实际行动，为双方合作创造必要条件。 【环球时报-环球网报道 记者白云怡】在29日的外交部例行记者会上，有媒体就中美元首会晤可能谈及 所谓"芬太尼关税"问题提问。 责任编辑：刘万里 SF014 ...

Group 1 - The core viewpoint is that U.S. Treasury Secretary Becerra expresses confidence that the Supreme Court will support Trump's tariffs, while also preparing alternative legal options in case the lower court's ruling is upheld [1][2] - The Federal Circuit Court ruled 7-4 that the International Emergency Economic Powers Act (IEEPA) does not grant Trump the authority to impose "fentanyl tariffs" and "reciprocal tariffs," with the decision effective before October 14 to allow for an appeal [1][2] - Becerra emphasizes the urgency of addressing trade imbalances and the fentanyl crisis, which results in approximately 70,000 American deaths annually, framing it as a reasonable basis for declaring a national emergency [2] Group 2 - Becerra plans to submit a legal brief highlighting the growing trade deficit, which he compares to the 2008-2009 financial crisis, suggesting that proactive measures could have prevented that disaster [2] - Alternative legal tools are available, including the Smoot-Hawley Tariff Act of 1930, which allows the President to impose tariffs of up to 50% on countries deemed discriminatory against U.S. commerce [2] - The Federal Circuit Court's ruling does not affect tariffs imposed under other legal authorities, such as those on steel and aluminum imports [3]

7月16日，美国总统特朗普在签署《全面遏制芬太尼贩运法案》前的几小时，突然话锋一转："我认为中国一直在帮助我们。"他特意强调中国在芬太尼问题 上"正在迈开大步"，甚至暗示中国"想做点什么"的态度值得肯定。戏剧性的是，当同日晚些时候特朗普真正落笔签署法案后，他的调门又陡然逆转。他再次 拾起那些被事实反复驳斥的说辞，声称"中国提供了大部分芬太尼"，甚至危言耸听地表示"有些人会说中国提供了所有芬太尼"。 这种自相矛盾的表演背后，关税——这个中方最关切的实质议题——他却绝口不提。特朗普对芬太尼问题的态度摇摆，始终与关税政策紧密相连。今年2 月，他就以中国"未能阻止芬太尼流入"为由，宣布对所有中国输美商品加征10%关税。这些指控出台时，美国海关边境保护局的记录却显示：自2019年5月 中国实施全球最严格的整类列管政策以来，美方再未查获过来自中国的芬太尼类物质。中方的反应迅速而有力。 在特朗普3月3日又迅速将税率提高至20%的第二天，中国就对美国农产品加征报复性关税，并精准"剑指"数十家美国企业。贸易关税争端迅速不断加码升 级，直到5月日内瓦会谈才达成临时休战——双方同意将双边关税下调115%，各自保留10%的"底线"。 ...

Group 1 - The core argument of the articles highlights the contradiction in the U.S. government's stance on fentanyl, where it blames China for the crisis while evidence suggests that China's regulations have actually saved lives in the U.S. [1][3] - A recent study indicates that China's 2019 ban on fentanyl exports has prevented nearly a thousand American deaths, challenging the narrative that China is the main culprit behind the fentanyl crisis in the U.S. [3][9] - The U.S. has imposed a 245% tariff on China, claiming it is a measure against fentanyl, but the reality is that the majority of fentanyl in the U.S. comes from Mexican drug cartels, not China [3][5] Group 2 - Despite China's proactive measures, the U.S. has not permanently classified fentanyl as a controlled substance, leading to ongoing issues with opioid prescriptions and misuse within the country [5][7] - The articles argue that the fentanyl crisis in the U.S. is largely a result of internal issues, including the pharmaceutical industry's profit motives and regulatory failures, rather than external factors related to China [7][9] - The economic impact of the trade war, including losses exceeding $1.5 trillion, is contrasted with the lives saved due to China's cooperation in drug control, suggesting that the U.S. has mismanaged the situation [9]

Core Viewpoint - The recent comments by a U.S. mayor about distributing fentanyl to the homeless highlight the severity of the fentanyl crisis in the U.S., which is often blamed on China, undermining cooperation in drug control between the two nations [1][4]. Group 1: U.S. Fentanyl Crisis - The U.S. has not permanently classified fentanyl, leading to worsening drug abuse and overdose issues, with synthetic opioids causing 75,000 overdose deaths in 2023, accounting for nearly 70% of all drug overdose deaths [2]. - The U.S. consumes 80% of the world's opioids despite having less than 5% of the global population, indicating a significant public health crisis [2]. - A poll by the Sihe Zhiyuan Foundation shows that most Americans believe drug cartels, users, and the government are responsible for the fentanyl crisis, suggesting a need for comprehensive policy reform [2]. Group 2: China's Drug Control Efforts - China maintains a "zero tolerance" policy towards drugs, including fentanyl, and has taken significant steps in drug control, including the comprehensive classification of fentanyl in 2019, making it the first country to do so [3]. - Since China's classification of fentanyl, there have been no reported cases of fentanyl smuggling from China to the U.S., as acknowledged by the U.S. State Department [3]. - China continues to enhance its control over precursor chemicals and collaborates with countries like the U.S. and Mexico to combat the issue of fentanyl and its precursors [3]. Group 3: U.S.-China Cooperation - The establishment of the U.S.-China drug control cooperation working group in 2024 provides a platform for both countries to address global drug issues collaboratively [4]. - Ongoing technical exchanges and regular communication between the two nations' drug enforcement agencies aim to strengthen cooperation in tackling the fentanyl crisis [4]. - China's strong opposition to the U.S. imposing tariffs under the pretext of the fentanyl issue emphasizes the need for mutual respect and factual acknowledgment in bilateral relations [4].